Form 4 holding
EVP, CHIEF SCIENTIFIC OFFICER
Repare Therapeutics Inc.
- Security class
- Common Shares
- Shares / value
- 80,297
- Estimated value
- $91,539
- Report date
- 12 Mar 2025
- Price
- $1.14
- Ownership
- Direct
Michael Zinda - EVP, CHIEF SCIENTIFIC OFFICER at Repare Therapeutics Inc.
Issuer-level insider activity
- Role
- Evp, Chief Scientific Officer
- Issuer ticker
- RPTX
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Michael Zinda since 25 Sep 2025
Reported holdings for Michael Zinda in Repare Therapeutics Inc.
Form 4 holding
EVP, CHIEF SCIENTIFIC OFFICER
Repare Therapeutics Inc.
- Security class
- Employee Stock Option (right to buy)
- Shares / value
- 85,000
- Estimated value
- Report date
- 04 Mar 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
Transaction history for Michael Zinda in Repare Therapeutics Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.